+ Description:

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 15.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: May 1, 2019
Date Series Expires: April 30, 2021

CME credit is obtained upon successful completion of an online post-test and evaluation.

Learning Objectives

At the conclusion of this activity, the participant will be able to:

• Describe the issues surrounding opioid crisis and the use of opioids for pain management including opioid guidelines, new legislation, addiction potential, and strategies to optimize outcomes
• Critically assess the data on the pros and cons of cannabinoids and the issues affecting their use in chronic pain treatment
• Discuss the evolving role of ketamine in the treatment of chronic and acute pain
• Review new developments within the spectrum of neuromodulation therapies
• Develop strategies to provide affordable pain care that addresses changes in regulatory, billing, and ethical challenges in pain practice
• List some emerging therapies for pain and describe their potential use in clinical practice
• Examine contemporary approaches to headache and back pain evaluation and treatment
• Review current evidence and apply relevant prescribing and management guidelines as they apply to pain management
• Demonstrate use of various technical skills needed to perform interventional pain procedures

Intended Audience

This conference is designed for all medical professionals with an interest in applying preventive, lifestyle, and integrative medicine approaches into their practice.

Topics/Speaker:

The Fundamentals

• Spinal Cord Stimulation – Mechanism of Action – Ricardo Vallejo, MD, PhD

• Evaluation and Treatment of Neck and Arm Pain – Following Cervical Fusion – Thomas Mroz, MD

• Sacroiliac Joint RFA: Indications, Better Technique, Better Outcomes? – David “DJ” Kennedy, MD

• Cervical Spine Surgery: Watchful Waiting vs. Decompression – Thomas Mroz, MD

• New Algorithm for Treatment of Chronic Abdominal Pain – Leo Kapural, MD, PhD

• Core Stability – David “DJ” Kennedy, MD

• Panel Discussion/Question and Answer

Regulatory, Billing and Ethical Challenges in Pain Practice

• Neuromodulation – Will Overuse Kill the Technology? – Timothy R. Deer, MD

• Effective Payer Negotiations – Damean Freas, DO

• CPT and RUC: How is a Code Created and Get Value? – Richard W. Rosenquist, MD

• Effective Billing for Neuromodulation Procedures – Robert Bolash, MD

• Medical and Ethical Concerns in Billing – Damean Freas, DO

Emerging Pharmacological and Interventional Treatment

• Basivertebral Nerve Ablation for Chronic Vertebrogenic Back Pain – David “DJ” Kennedy, MD

• The ReActiv8 Trial – Christopher J. Gilligan, MD

• CGRP Antagonists – MaryAnn Mays, MD

• Nerve Growth Factor – Mark S. Wallace, MD

• Nav1.7 as a Pharmacogenomic Target for Pain – Robert Bolash, MD

Neuromodulation: Effective Utilization of Targets, Techniques, and Devices

• Neurostimulation: From Inception to the Future – Nagy Mekhail, MD, PhD

• Tonic Stimulation – Ricardo Vallejo, MD, PhD

• Burst Stimulation – Timothy R. Deer, MD

• High Frequency Stimulation – Leo Kapural, MD, PhD

• Feedback Modified Stimulation – Nagy Mekhail, MD, PhD

• Intrathecal Drug Delivery – Robert Bolash, MD

• Dorsal Root Ganglion Stimulation – Timothy R. Deer, MD

Neuromodulation – Changing Paradigms and Devices: How Do I Choose the Best One for My Patient?

• Matching the Diagnosis and the Technique/Device for the Best Patient Outcome – A Case Discussion with the Experts – Nagy Mekhail, MD, PhD

• Panel Discussion/Question and Answer

The Opioid Crisis

• Buprenorphine: A Viable Alternative? – Robert Bolash, MD

• Pharmacogenomics: Fad or the Future? – Jennifer Hockings, PharmD, PhD

• Evolving Role of Pain Physicians in Identifying and Treating Opioid Use Disorder – Richard W. Rosenquist, MD

• Opioid Stewardship at the Enterprise Level – Christopher J. Gilligan, MD

• FDA Approved Direct to Consumer Pharmacogenomic Testing: How Do I Respond? – Jennifer Hockings, PharmD, PhD

Ketamine for Pain Medicine

• Ketamine for Chronic Pain – Samuel Samuel, MD

• Ketamine for Acute Pain – Sree Kolli, MD

• Ketamine: Miracle Drug or Latest Fad? – Teresa Dews, MD

• Contraindications to Ketamine Treatment – Samuel Samuel, MD

• Non-Pain Related Applications of Ketamine – Christopher J. Gilligan, MD

• Ketamine for CRPS – Jijun Xu, MD, PhD

• Panel Discussion/Question and Answer

Medical Marijuana

• Role of Cannabinoids in Chronic Pain Treatment – Mark S. Wallace, MD

• Adverse Effects of Cannabinoids – Scott Petersen, PA-C

• Oils, Edibles, Smoking, and Vaping: How Do You Decide? – Mark S. Wallace, MD

Headaches

• Evaluating the Headache Patient: When is Imaging Indicated? – Imanuel R. Lerman, MD

• Rational Approach to Pharmacological Migraine Treatment – MaryAnn Mays, MD

• Interventional Approaches to Headache Management – Samuel Samuel, MD

• Adverse Effects of Pharmacological Treatments – MaryAnn Mays, MD

• Panel Discussion/Question and Answer